Bone Biologics Corp
BBLG· Nasdaq
BBLGBone Biologics Corp
Filed Nov 14, 2025 · 10-Q · 45 days after period end · 0001493152-25-023563
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Net Income | -$666.74K | -$941.00K | -$1.92M | -$1.22M |
| EPS Diluted | -$0.37 | -$14.21 | -$4.90 | -$3.53 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bone Biologics Corp · CIK 1419554 · Engraved from SEC EDGAR
ended Sep 30, 2025 · filed Nov 14, 2025 · 45 d after period end
